Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)
Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)
Recruiting · NCT07346859 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Primary Immunodeficiency Diseases, hereditary disease, immune system disorder, inborn error of immunity | Recruiting | Phase 3 | 2026-01-16 | NCT07346859 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Biopharma Plasma LLC | 1 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.